{"abstract":"The Administrator of the Drug Enforcement Administration is providing this notice of intent to publish a temporary order to schedule five synthetic benzodiazepine substances, as identified in this notice, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these five specified controlled substances.","action":"Proposed amendment; notice of intent.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2022/12/23/2022-27278.html","cfr_references":[{"chapter":null,"citation_url":null,"part":1308,"title":21}],"citation":"87 FR 78887","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"This notice of intent is effective December 23, 2022.","disposition_notes":null,"docket_ids":["Docket No. DEA-989"],"dockets":[{"supporting_documents":[{"title":"DEA989 HHS 8-Factor Analysis","document_id":"DEA-2022-0145-0008"},{"title":"DEA989 DEA 8-Factor Analysis","document_id":"DEA-2022-0145-0007"},{"title":"SIGNED - Benzodiazepines 811h no objection ASH to DEA.VAS","document_id":"DEA-2022-0145-0003"},{"title":"DEA 3-Factor Analysis Etizolam Flualprazolam Clonazolam Diclazepam Flu...","document_id":"DEA-2022-0145-0002"}],"agency_name":"DEA","documents":[{"comment_count":0,"comment_start_date":"2022-12-23","updated_at":"2023-02-27T19:46:54.215-05:00","comment_url":"https://www.regulations.gov/commenton/DEA-2022-0145-0001","allow_late_comments":null,"id":"DEA-2022-0145-0001","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":4,"id":"DEA-2022-0145","title":"Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989)"}],"document_number":"2022-27278","effective_on":"2022-12-23","end_page":78892,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2022/12/23/2022-27278.xml","html_url":"https://www.federalregister.gov/documents/2022/12/23/2022-27278/schedules-of-controlled-substances-temporary-placement-of-etizolam-flualprazolam-clonazolam","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2022-27278?publication_date=2022-12-23","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2022-12-23/2022-27278/mods.xml","not_received_for_publication":null,"page_length":6,"page_views":{"count":16766,"last_updated":"2026-04-04 16:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-12-23/pdf/2022-27278.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-27278.pdf?1671716724","publication_date":"2022-12-23","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2022/12/23/2022-27278.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"SIGNED - Benzodiazepines 811h no objection ASH to DEA.VAS","document_id":"DEA-2022-0145-0003"},{"title":"DEA 3-Factor Analysis Etizolam Flualprazolam Clonazolam Diclazepam Flu...","document_id":"DEA-2022-0145-0002"}],"comments_count":0,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2022-0145","supporting_documents_count":2,"docket_id":"DEA-2022-0145","document_id":"DEA-2022-0145-0001","regulation_id_number":null,"title":"Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989)","checked_regulationsdotgov_at":"2023-02-28T00:46:53Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":78887,"subtype":null,"title":"Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I","toc_doc":"Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I","toc_subject":"Schedule of Controlled Substances:\n","topics":["Administrative practice and procedure","Drug traffic control","Reporting and recordkeeping requirements"],"type":"Proposed Rule","volume":87}